HERZ, cilt.43, sa.5, ss.455-460, 2018 (SCI-Expanded)
Background. Biomarkers play an important role in the risk stratification of patients with heart failure (HF). Recent studies have shown that soluble suppression of tumorigenicity 2 (sST2), a member of the interleukin 1 receptor family, is associated with disease prognosis in acute and chronic HE In this study we aimed to investigate the relation between sST2 level and functional capacity in outpatients with systolic HE.